IMS medical database refers to Amy's (IMS? Health) health brand, which mainly provides business information and business consulting services for the medical and health industry. IMS？ Healthy? Inc. mainly provides regional sales reports, industry tracking reports and industry forecasting services. 20 16 and Quintiles were merged into QuintilesIMS, and 20 17 was renamed IQVIA. So instant messaging system now? Healthy? It means IQVIA.
As a pure information service company, IMS Medical Database (now IQVIA) does not participate in drug research and development, clinical trials and treatment. What is good enough to be favored by pharmaceutical companies? The author believes that a biomedical data information service company that can serve pharmaceutical companies and related medical workers well must have two core conditions. One is to have the ability to collect data through multiple channels in professional fields and integrate cleaning data to ensure the accurate and reliable data source of customer inquiries; Second, it has many functions, such as good platform underlying framework design, high-precision big data algorithm, visualization, multi-data association, data subscription tracking and so on. Users around the world should also consider their usage habits, which is why IMS medical database is very unfriendly to China people in China. It is also one of the reasons for the continuous decline of its market before the merger, but it is far from the truth.
Because the early IMS medical database occupied the monopoly position in the market, many senior medical workers would associate it with IMS (now IQVIA), but the data survey in the sinking market in China is not as good as that of domestic medical data service providers, and both the drug research and development data and the market data information research are inferior. In particular, IQVIA, as an American multinational company, is not used to cultural attributes, systems, business habits, etc. in the fields of cooperative data collection of pharmaceutical companies. In recent years, domestic medical data service providers, such as Yunyun and Minei, rely on their deep cultivation in medical data, making medical data more detailed than foreign databases in some fields and more in line with the style interface of domestic users. With the rapid development of domestic medical data, the original market share of IMS (now IQVIA) medical database is gradually declining.
At present, whenever the medical database business is mentioned in China, pharnexcloud (Pharmaceutical Rong Yun) always comes to mind. It is the database with the widest coverage in domestic medical data, and it is also the database that major pharmaceutical companies often compare with foreign IQVIA, informa and cortellis before purchasing.
pharnexcloud
Pharnexcloud medical database: covers the whole life cycle data of biomedicine, and nine sections of data such as drug research and development, drug sales, market information, generic drugs, medical devices, production inspection, rational drug use, APIs and global drugs.
Coverage: Covers nearly 80 mainstream countries around the world and many domestic provincial and city-level channels.
Data source: It involves thousands of data sources, including but not limited to (① medical information: laboratory research, internal meetings, professional reports, patents, trademarks, technical implementation documents, academic meetings, technical reports, scientific journals, documents, etc. ② Medical database: heterogeneous resource platform and medical big data processing platform based on cloud computing and cloud storage. ③ Official medical data: official resources such as institutions, information, enterprise announcements and reports, medical conferences, news information, investor pressure drop, company annual report, official website medical and health institutions, official website pharmaceutical companies, medical journals, etc. )
Value-added service: ① Special person meets the demand and team solves the problem. (2) Salon, lecture tour, summit, project transaction, demand docking and other activities support, and can join its pharmaceutical integration circle ecological chain (currently the top ecological chain in the domestic pharmaceutical field).
Let's take the most available data of IQVIA in China (China Hospital Drug Statistics Report CHPA? ) and pharnexcloud? (national hospital sales data) intuitive comparison.
IQVIA database (China hospital drug statistics report)? Based on 9454 hospitals (≥ 100 beds), the sample design covers 255 cities. There are only about 1000 sample hospitals, and the total number that can be calculated is about 8,000.
IQVIA database contains more than 80 thousand global medical transaction information;
Pharnexcloud database (national hospital sales data), which is based on the sample design of 10000 hospitals (secondary hospitals and above), covering 24 provinces and all key urban areas in China, with more than 2200 stratified samples. More than 9,000 sample hospitals can be estimated through hierarchical amplification of professional computing models. This is the coverage scale that other databases at home and abroad can't match.
The global medical transaction information of pharne cloud database is 19653 (the author has insufficient authority, and can only find the data of 202 1 till now), so it can be inferred that the global medical transaction information data of pharne cloud is also higher than that of IQVIA database.
In terms of medical data (quantity, source, algorithm, update tracking), especially in the application of domestic medical database, pharnexcloud is recommended, which is unmatched by other data service providers at home and abroad in terms of data intelligence, business cooperation and ownership value.